Stay updated with breaking news from 91307c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
United Therapeutics (NASDAQ:UTHR – Get Free Report) will be announcing its 09/30/2023 earnings results before the market opens on Wednesday, November 1st. Analysts expect the company to announce earnings of $4.88 per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link. United Therapeutics (NASDAQ:UTHR – […]
Coldstream Capital Management Inc. grew its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 4.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,094 shares of the biotechnology company’s stock after purchasing an additional 86 shares during the period. Coldstream […]
StockNews.com assumed coverage on shares of United Therapeutics (NASDAQ:UTHR – Free Report) in a research report released on Thursday morning. The firm issued a buy rating on the biotechnology company’s stock. UTHR has been the topic of a number of other research reports. HC Wainwright restated a buy rating and set a $300.00 price objective […]
TFB Advisors LLC increased its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 28.3% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,954 shares of the biotechnology company’s stock after acquiring an additional 431 shares during the quarter. […]
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) EVP Paul A. Mahon sold 6,000 shares of the business’s stock in a transaction that occurred on Thursday, September 21st. The shares were sold at an average price of $222.19, for a total value of $1,333,140.00. Following the completion of the sale, the executive vice president now […]